Hans-Joachim E Schmoll (Hans-Joachim Schmoll)

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 9

Top Topics

Prognostic Factors

Locally Advanced

Top Venues

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Future oncology (London, England)

Journal of cancer research and clinical oncology

JCO clinical cancer informatics

This page only lists publications with an associated author ORCID identifier.

Publications

Benoist Chibaudel, Morteza Raeisi, Romain Cohen, Greg Yothers, Richard M Goldberg, Jean-Baptiste Bachet, Norman Wolmark, Takayuki Yoshino, Hans-Joachim E Schmoll, Rachel Kerr, Sara Lonardi, Thomas J George, Einat Shacham-Shmueli, Qian Shi, Thierry André, Aimery deGramont
Assessment of the Addition of Oxaliplatin to Fluoropyrimidine-Based Adjuvant Chemotherapy in Patients With High-Risk Stage II Colon Cancer: An ACCENT Pooled Analysis. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Marinde J G Bond, Maarten van Smeden, Koen Degeling, Chiara Cremolini, Hans-Joachim E Schmoll, Carlotta Antoniotti, Sara Lonardi, Sabina Murgioni, Daniele Rossini, Stefan Ibach, Miriam Koopman, Rutger-Jan Swijnenburg, Cornelis J A Punt, Katie M O'Brien, Johannes J M Kwakman
Predicting Benefit From FOLFOXIRI Plus Bevacizumab in Patients With Metastatic Colorectal Cancer. JCO clinical cancer informatics 8 (2024)
Claire Gallois, Qian Shi, Levi D Pederson, Thierry André, Timothy J Iveson, Alberto F Sobrero, Steven R Alberts, Aimery deGramont, Jeffrey A Meyerhardt, Thomas J George, Hans-Joachim E Schmoll, Ioannis Souglakos, Andrea Harkin, Roberto Labianca, Frank A Sinicrope, Eiji Oki, Anthony Frank Shields, Ioannis Boukovinas, Rachel Kerr, Sara Lonardi, Greg Yothers, Takayuki Yoshino, Richard M Goldberg, Gilles Manceau, Demetris Papamichael
Oxaliplatin-Based Adjuvant Chemotherapy in Older Patients With Stage III Colon Cancer: An ACCENT/IDEA Pooled Analysis of 12 Trials. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (19) (2024)
Claire Gallois, Qian Shi, Levi D Pederson, Thierry André, Timothy J Iveson, Alberto F Sobrero, Steven R Alberts, Aimery deGramont, Jeffrey A Meyerhardt, Thomas J George, Hans-Joachim E Schmoll, Ioannis Souglakos, Andrea Harkin, Roberto Labianca, Frank A Sinicrope, Eiji Oki, Anthony Frank Shields, Ioannis Boukovinas, Rachel Kerr, Sara Lonardi, Greg Yothers, Takayuki Yoshino, Richard M Goldberg, Gilles Manceau, Demetris Papamichael
Oxaliplatin-Based Adjuvant Chemotherapy in Older Patients With Stage III Colon Cancer: An ACCENT/IDEA Pooled Analysis of 12 Trials. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Hans-Joachim E Schmoll, Murielle E Mauer, Sandrine Marreaud, Alexander Stein
Reply to P. Potemski and K. Bujko. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 39 (11) (2021)
Hans-Joachim E Schmoll, Alexander Stein, Eric Van Cutsem, Timothy Price, Ralf D Hofheinz, Bernard Nordlinger, Jean-François Daisne, Jos Janssens, Baruch Brenner, Hans Reinel, Stephan Hollerbach, Karel Caca, Florian Fauth, Carla V Hannig, John Zalcberg, Niall Tebbutt, Murielle E Mauer, Sandrine Marreaud, Manfred P Lutz, Karin Haustermans
Pre- and Postoperative Capecitabine Without or With Oxaliplatin in Locally Advanced Rectal Cancer: PETACC 6 Trial by EORTC GITCG and ROG, AIO, AGITG, BGDO, and FFCD. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 39 (1) (2020)
Hans-Joachim E Schmoll
The future of colorectal cancer research: an interview with. Future oncology (London, England) (2020)
Hans-Joachim E Schmoll
The future of colorectal cancer research: an interview with Hans Schmoll. Future oncology (London, England) 16 (29) (2020)
Hans-Joachim E Schmoll, Dirk Arnold, Aimery de Gramont, Michel Ducreux, Axel Grothey, Peter J O'Dwyer, Eric Van Cutsem, Frank Hermann, Ivan Bosanac, Belguendouz Bendahmane, Christoph Mancao, Josep Tabernero
MODUL-a multicenter randomized clinical trial of biomarker-driven maintenance therapy following first-line standard induction treatment of metastatic colorectal cancer: an adaptable signal-seeking approach. Journal of cancer research and clinical oncology 144 (6) (2018)